Brief: Sagimet Biosciences- Anthony Rimac Provided Notice Of His Intent To Step Down As CFO
29/12/2023 21:55
Dec 29 (Reuters) - Sagimet Biosciences Inc SGMT.O :
* SAGIMET BIOSCIENCES INC - ON DECEMBER 28, ANTHONY RIMAC
PROVIDED
NOTICE OF HIS INTENT TO STEP DOWN AS CFO OF SAGIMET BIOSCIENCES
INC.
* SAGIMET BIOSCIENCES INC - INTENDS TO APPOINT JOE ORITI AS
INTERIM PRINCIPAL FINANCIAL OFFICER OF COMPANY FOLLOWING RIMAC'S
DEPARTURE
Further company coverage: SGMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sagimet Biosciences
See all newsBrief: Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Brief: Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Brief: Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026
Brief: Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage